Search Results - Chia-Chi Lin
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
RET mutations and medullary thyroid cancer by Chia-Chi Lin
Published in Journal of the Formosan Medical Association (2011-11-01)Get full text
Article -
2
A Content Analysis of Online Physician Information by Chia-Chi Lin, Ming-Hsin Phoebe Chiu
Published in Jiàoyù zīliào yǔ túshūguǎn xué (2019-07-01)Get full text
Article -
3
-
4
The interrelationship of depression, stigma, and suicide risk among patients with bipolar disorder and their caregivers: a six-month follow-up study by Chia-Chi Lin, Yu Lee, Nien-Mu Chiu, Pao-Yen Lin, Yu-Chi Huang, Chi-Fa Hung, Liang-Jen Wang
Published in International Journal of Bipolar Disorders (2025-04-01)Get full text
Article -
5
Suicide risks among caregivers of patients with depressive disorders by Chia-Chi Lin, Yu-Chi Huang, Yu Lee, Pao-Yen Lin, Nien-Mu Chiu, Chi-Fa Hung, Liang-Jen Wang
Published in Journal of International Medical Research (2024-07-01)Get full text
Article -
6
Polyoxygenated Terpenoids and Polyketides from the Roots of <i>Flueggea virosa</i> and Their Inhibitory Effect against SARS-CoV-2-Induced Inflammation by Ju-Chien Cheng, Yi-Ju Chen, Chi-Wen Chuang, Ya-Hsuan Chao, Hui-Chi Huang, Chia-Chi Lin, Chih-Hua Chao
Published in Molecules (2022-12-01)Get full text
Article -
7
RNA recombination in Hepatitis delta virus: Identification of a novel naturally occurring recombinant by Chia-Chi Lin, Chi-Ching Lee, Siao-Han Lin, Po-Jung Huang, Hsin-Pai Li, Yu-Sun Chang, Petrus Tang, Mei Chao
Published in Journal of Microbiology, Immunology and Infection (2017-12-01)Get full text
Article -
8
A Longitudinal Historical Population Database in Asia. The Taiwanese Historical Household Registers Database (1906–1945) by Chia-chi Lin, Shu-juo Chen, Ying-chang Chuang, Wen-shan Yang, James Wilkerson, Ying-hui Hsieh, Ko-hua Yap, Yu-lin Huang
Published in Historical Life Course Studies (2020-12-01)Get full text
Article -
9
A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement by Yun Chiang, Jason Chia-Hsien Cheng, Chao-Yuan Huang, Yu-Chieh Tsai, Chia-Chi Lin, Chih-Hung Hsu, Ann-Lii Cheng, Yeong-Shiau Pu
Published in Journal of the Formosan Medical Association (2017-09-01)Get full text
Article -
10
Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer by Jhe‐Cyuan Guo, Chia‐Lang Hsu, Min‐Shu Hsieh, Chia‐Chi Lin, Ta‐Chen Huang, Hung‐Yang Kuo, Yu‐Yun Shao, Chih‐Hung Hsu
Published in Thoracic Cancer (2023-08-01)Get full text
Article -
11
ADAR2 deficiency ameliorates non‐alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1 by Mei‐Lang Kung, Tai‐Hua Yang, Chia‐Chi Lin, Jia‐Yun Ho, Tzu‐Chi Hung, Chih‐Hsiang Chang, Kuan‐Wen Huang, Chien‐Chin Chen, Yun‐Wen Chen
Published in Journal of Cachexia, Sarcopenia and Muscle (2024-06-01)Get full text
Article -
12
Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front‐line chemotherapy regimens by Wei‐Li Ma, Chia‐Chi Lin, Feng‐Ming Hsu, Jang‐Ming Lee, Jin‐Shing Chen, Yen‐Lin Huang, Yih‐Leong Chang, Chin‐Hao Chang, James Chih‐Hsin Yang
Published in Cancer Medicine (2022-09-01)Get full text
Article -
13
Sabatolimab in combination with spartalizumab in patients with non-small cell lung cancer or melanoma who received prior treatment with anti-PD-1/PD-L1 therapy: a phase 2 multicent... by Toshihiko Doi, David Tai, Dong-Wan Kim, F Stephen Hodi, Sofie Wilgenhof, Catherine Sabatos-Peyton, Giuseppe Curigliano, Chia-Chi Lin, Armando Santoro, Alexandros Xyrafas, Nicolas Mach, Sebastian Szpakowski, Shripad Chitnis, Sabine Gutzwiller, Alessandro Pastore
Published in BMJ Open (2024-08-01)Get full text
Article -
14
629-C Phase 2 safety and efficacy of oral CCR4 antagonist FLX475 (tivumecirnon) plus pembrolizumab in subjects with non-small cell lung cancer not previously treated with checkpoin... by Jameel Muzaffar, Tae Min Kim, Julie Brahmer, Dirk G Brockstedt, Chia-Chi Lin, Michael Chisamore, Ki Hyeong Lee, Paul D Kassner, Nuttapong Ngamphaiboon, William Ho, Nicole Nasrah, Pratibha Desai, Yin-Hsun Feng, Shang-Yin Wu, Rakesh Kumar Goyal
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Article -
15
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors by Thomas Yau, Ignacio Garrido-Laguna, Pierre-Eric Juif, Markus Joerger, Anna Spreafico, Todd M Bauer, Chia-Chi Lin, Armando Santoro, Richard Greil, Helen Evans, Marc Pelletier, Toshikiko Doi, Maria-Elisabeth Goebeler, Viviana Cremasco, Marie Luise Hütter-Krönke, Antonella Perotti, Darlene Lu, Louise Barys, Claire Fabre
Published in Journal for ImmunoTherapy of Cancer (2023-11-01)Get full text
Article -
16
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors by Hans Gelderblom, Patrick M Forde, Aung Naing, Matthew Taylor, Jennifer Mataraza, Marcus O Butler, Todd M Bauer, Justin F Gainor, Chia-Chi Lin, Sunil Sharma, Maria Ochoa de Olza, Andrea Varga, Jan H M Schellens, Hongqian Wu, Haiying Sun, Antonio P Silva, Jason Faris, Scott Cameron
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article -
17
Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors by Yun Zhang, Bhumsuk Keam, Jayesh Desai, Ben Markman, Shahneen Sandhu, Michael Millward, Yoon-Koo Kang, Chia-Chi Lin, Yee Chao, Sanjeev Deva, Jong Seok Lee, Chia-Jui Yen, Michael Jameson, Ming-Mo Hou, Chang-Hsien Lu, Kun-Ming Rau, Kyung-Hun Lee, Lisa Horvath, Michael Friedlander, Andrew Hill, Paula Barlow, Chi-Yuan Wu, Liang Liang, John Wu, Virginia Paton
Published in Journal for ImmunoTherapy of Cancer (2020-05-01)Get full text
Article -
18
Targeting CD38 and PD-1 with isatuximab plus cemiplimab in patients with advanced solid malignancies: results from a phase I/II open-label, multicenter study by Rui Wang, Antoine Italiano, Shubham Pant, Johann De Bono, Todd M Bauer, Christophe Massard, Chia-Chi Lin, Roberto Iacovelli, Martin Gutierrez, Mansoor Saleh, Helen Lee, Gennaro Daniele, Paolo Andrea Zucali, Marielle Chiron, Bradley C Carthon, Robin Meng, Giovanni Abbadessa, Marcello Tucci, Wu-Chou Su, Alastair Greystoke, Ying-Chun Shen, Matteo Perrino, Yingwen Dong, Laure Loumagne, Lucie Lépine
Published in Journal for ImmunoTherapy of Cancer (2022-01-01)Get full text
Article -
19
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC by Bin-Chi Liao, MD, Wei-Hsun Hsu, MD, Jih-Hsiang Lee, MD, Ching-Yao Yang, MD, PhD, Tzu-Hsiu Tsai, MD, PhD, Wei-Yu Liao, MD, PhD, Chao-Chi Ho, MD, PhD, Chia-Chi Lin, MD, PhD, Jin-Yuan Shih, MD, PhD, Chong-Jen Yu, MD, PhD, Ross A. Soo, M.B.B.S., James Chih-Hsin Yang, MD, PhD
Published in JTO Clinical and Research Reports (2021-01-01)Get full text
Article -
20
Phase 1b Open-Label Trial of Afatinib Plus Xentuzumab (BI 836845) in Patients With EGFR Mutation-Positive NSCLC After Progression on EGFR Tyrosine Kinase Inhibitors by Keunchil Park, MD, PhD, Daniel Shao Weng Tan, BSc, M.B.B.S., MRCP, Wu-Chou Su, MD, Byoung Chul Cho, MD, PhD, Sang-We Kim, MD, PhD, Ki Hyeong Lee, MD, PhD, Chin-Chou Wang, MD, MS, Takashi Seto, MD, Dennis Chin-Lun Huang, MD, Helen Hayoun Jung, BS, RPh, Ming-Chi Hsu, PhD, Thomas Bogenrieder, MD, PhD, Chia-Chi Lin, MD, PhD
Published in JTO Clinical and Research Reports (2021-09-01)Get full text
Article
